Philippe Rousseau
Plus aucun poste en cours
Profil
Philippe Rousseau formerly worked at CYTOO SA, as Chief Executive Officer from 2013 to 2018, Abcdx SA, as Deputy Chief Executive Officer from 2019 to 2020, COPEBAT SA, as Director General, Pherecydes Pharma SA, as Director, Chief Financial & Operating Officer from 2020 to 2022, Anesten LLC, as Managing Director from 2010 to 2018, Serono Genetics Institute SA, as Vice President-Finance, Vivalis SA, as Chief Financial Officer & Head-Investor Relations from 2009 to 2013, Therabron Therapeutics, Inc., as Chief Financial Officer, Exonhit, as Chief Executive & Financial Officer from 2003 to 2009, and Biophytis SA, as Chief Financial & Administrative Officer from 2022 to 2023.
Mr. Rousseau received his graduate degree in 1994 from Hautes Etudes Commerciales and Masters Business Admin degree from École des Hautes Études Commerciales de Paris.
Anciens postes connus de Philippe Rousseau
Sociétés | Poste | Fin |
---|---|---|
BIOPHYTIS S.A. | Directeur Financier/CFO | 22/05/2023 |
PHERECYDES PHARMA | Directeur Financier/CFO | 19/05/2022 |
Abcdx SA
Abcdx SA Medical SpecialtiesHealth Technology Abcdx SA is a Swiss-based company that specializes in the discovery, clinical validation, and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries. The company is based in Geneva, Switzerland. The company combines its unique expertise in brain biomarker discovery, awareness, and clinical validation. Abcdx was founded by Charles Sanchez and Joan Montaner, and Charles Sanchez has been the CEO since incorporation. | Corporate Officer/Principal | 01/01/2020 |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Directeur Général | 01/01/2018 |
Anesten LLC | Corporate Officer/Principal | 01/01/2018 |
Formation de Philippe Rousseau
Hautes Etudes Commerciales | Graduate Degree |
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOPHYTIS S.A. | Health Technology |
Entreprise privées | 9 |
---|---|
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Health Technology |
Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Health Technology |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
COPEBAT SA
COPEBAT SA Wholesale DistributorsDistribution Services COPEBAT SA supplies storage and distribution of materials for carpenters. It wholesales wood, construction materials, and sanitary systems. The company was founded in March 2003 and is headquartered in Vineuil, France. | Distribution Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Health Technology |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
Abcdx SA
Abcdx SA Medical SpecialtiesHealth Technology Abcdx SA is a Swiss-based company that specializes in the discovery, clinical validation, and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries. The company is based in Geneva, Switzerland. The company combines its unique expertise in brain biomarker discovery, awareness, and clinical validation. Abcdx was founded by Charles Sanchez and Joan Montaner, and Charles Sanchez has been the CEO since incorporation. | Health Technology |
Anesten LLC |